Mark Fishman. Interview by Asher Mullard.
Mark
M
Fishman
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002454:Cell Differentiation / Q000187:drug effects; D055808:Drug Discovery / Q000379:methods / Q000639:trends*; D004345:Drug Industry / Q000379:methods / Q000639:trends*; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D013234:Stem Cells / Q000166:cytology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C541220:canakinumab